Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.
This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.
麻豆原创 Analysis and Insights: Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创
The global Pharmaceutical and Biotechnology Environmental Monitoring market is projected to grow from US$ 1001 million in 2024 to US$ 1388 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pharmaceutical and Biotechnology Environmental Monitoring market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmaceutical and Biotechnology Environmental Monitoring, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical and Biotechnology Environmental Monitoring, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical and Biotechnology Environmental Monitoring revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical and Biotechnology Environmental Monitoring market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical and Biotechnology Environmental Monitoring revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Danaher Corporation
Thermo Fisher Scientific
Merck
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala
Particle Measurement Systems
Hanwell
Novatek
Segment by Type
Monitoring Equipment
Media
Software
Microbiology Service
Segment by Application
Pharmaceutical Industrial
Biotechnology Industrial
Academic Institutions
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical and Biotechnology Environmental Monitoring in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical and Biotechnology Environmental Monitoring companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical and Biotechnology Environmental Monitoring revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monitoring Equipment
1.2.3 Media
1.2.4 Software
1.2.5 Microbiology Service
1.3 麻豆原创 by Application
1.3.1 Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industrial
1.3.3 Biotechnology Industrial
1.3.4 Academic Institutions
1.3.5 Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Perspective (2019-2030)
2.2 Global Pharmaceutical and Biotechnology Environmental Monitoring Growth Trends by Region
2.2.1 Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical and Biotechnology Environmental Monitoring Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Pharmaceutical and Biotechnology Environmental Monitoring Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Dynamics
2.3.1 Pharmaceutical and Biotechnology Environmental Monitoring Industry Trends
2.3.2 Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Drivers
2.3.3 Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Challenges
2.3.4 Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmaceutical and Biotechnology Environmental Monitoring by Players
3.1.1 Global Pharmaceutical and Biotechnology Environmental Monitoring Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical and Biotechnology Environmental Monitoring Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmaceutical and Biotechnology Environmental Monitoring, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Concentration Ratio
3.4.1 Global Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical and Biotechnology Environmental Monitoring Revenue in 2023
3.5 Global Key Players of Pharmaceutical and Biotechnology Environmental Monitoring Head office and Area Served
3.6 Global Key Players of Pharmaceutical and Biotechnology Environmental Monitoring, Product and Application
3.7 Global Key Players of Pharmaceutical and Biotechnology Environmental Monitoring, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical and Biotechnology Environmental Monitoring Breakdown Data by Type
4.1 Global Pharmaceutical and Biotechnology Environmental Monitoring Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Pharmaceutical and Biotechnology Environmental Monitoring Forecasted 麻豆原创 Size by Type (2025-2030)
5 Pharmaceutical and Biotechnology Environmental Monitoring Breakdown Data by Application
5.1 Global Pharmaceutical and Biotechnology Environmental Monitoring Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Pharmaceutical and Biotechnology Environmental Monitoring Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size (2019-2030)
6.2 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type
6.2.1 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Type (2019-2030)
6.3 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application
6.3.1 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Application (2019-2030)
6.4 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country
6.4.1 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size (2019-2030)
7.2 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type
7.2.1 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Type (2019-2030)
7.3 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application
7.3.1 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Application (2019-2030)
7.4 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country
7.4.1 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size (2019-2030)
8.2 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type
8.2.1 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2019-2024)
8.2.2 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2025-2030)
8.2.3 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Type (2019-2030)
8.3 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application
8.3.1 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2019-2024)
8.3.2 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2025-2030)
8.3.3 China Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size (2019-2030)
9.2 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type
9.2.1 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Type (2019-2030)
9.3 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application
9.3.1 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Application (2019-2030)
9.4 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Region
9.4.1 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pharmaceutical and Biotechnology Environmental Monitoring 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Danaher Corporation
11.1.1 Danaher Corporation Company Details
11.1.2 Danaher Corporation Business Overview
11.1.3 Danaher Corporation Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.1.4 Danaher Corporation Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.1.5 Danaher Corporation Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.3.4 Merck Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.3.5 Merck Recent Developments
11.4 Eurofins Sinensis
11.4.1 Eurofins Sinensis Company Details
11.4.2 Eurofins Sinensis Business Overview
11.4.3 Eurofins Sinensis Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.4.4 Eurofins Sinensis Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.4.5 Eurofins Sinensis Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.5.4 Lonza Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.5.5 Lonza Recent Developments
11.6 Biomerieux
11.6.1 Biomerieux Company Details
11.6.2 Biomerieux Business Overview
11.6.3 Biomerieux Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.6.4 Biomerieux Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.6.5 Biomerieux Recent Developments
11.7 VAI
11.7.1 VAI Company Details
11.7.2 VAI Business Overview
11.7.3 VAI Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.7.4 VAI Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.7.5 VAI Recent Developments
11.8 Cosasco
11.8.1 Cosasco Company Details
11.8.2 Cosasco Business Overview
11.8.3 Cosasco Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.8.4 Cosasco Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.8.5 Cosasco Recent Developments
11.9 RMONI
11.9.1 RMONI Company Details
11.9.2 RMONI Business Overview
11.9.3 RMONI Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.9.4 RMONI Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.9.5 RMONI Recent Developments
11.10 Amphenol Advanced Sensors
11.10.1 Amphenol Advanced Sensors Company Details
11.10.2 Amphenol Advanced Sensors Business Overview
11.10.3 Amphenol Advanced Sensors Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.10.4 Amphenol Advanced Sensors Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.10.5 Amphenol Advanced Sensors Recent Developments
11.11 Vaisala
11.11.1 Vaisala Company Details
11.11.2 Vaisala Business Overview
11.11.3 Vaisala Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.11.4 Vaisala Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.11.5 Vaisala Recent Developments
11.12 Particle Measurement Systems
11.12.1 Particle Measurement Systems Company Details
11.12.2 Particle Measurement Systems Business Overview
11.12.3 Particle Measurement Systems Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.12.4 Particle Measurement Systems Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.12.5 Particle Measurement Systems Recent Developments
11.13 Hanwell
11.13.1 Hanwell Company Details
11.13.2 Hanwell Business Overview
11.13.3 Hanwell Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.13.4 Hanwell Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.13.5 Hanwell Recent Developments
11.14 Novatek
11.14.1 Novatek Company Details
11.14.2 Novatek Business Overview
11.14.3 Novatek Pharmaceutical and Biotechnology Environmental Monitoring Introduction
11.14.4 Novatek Revenue in Pharmaceutical and Biotechnology Environmental Monitoring Business (2019-2024)
11.14.5 Novatek Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Danaher Corporation
Thermo Fisher Scientific
Merck
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala
Particle Measurement Systems
Hanwell
Novatek
听
听
*If Applicable.
